About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, September 9th, 2013

The QualityStocks
Daily Stock List


Xhibit Corp. (XBTC)

RedChip reported earlier on Xhibit Corp. (XBTC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Headquartered in Tempe, Arizona, Xhibit Corp. is a digital marketing company. The Company designs digital ecosystems to support business brands. Xhibit is a full-service provider concentrating on digital products and solutions. The Company also owns and operates SkyMall. This is a multi-channel, direct marketer offering high-quality, ground-breaking merchandise from top direct marketers and manufacturers via the SkyMall catalog and website, SkyMall.com.

SkyMall Ventures (SMV), established in 1999, is a provider of merchandise, gift cards, and experiential rewards reaching millions of loyalty program members in some of the most well-regarded loyalty programs in the nation. The SkyMall catalog is seen by approximately 88 percent of all domestic air passengers reaching over 650 million travelers each year.

In addition, by way of their other subsidiaries, Xhibit provides cloud based marketing and technology development services and solutions. These are focused on digital advertising, mobile and social media development, as well as CRM (Customer Relationship Management) solutions.

The Company refers to their design cycle as "sustainable digital ecosystem development." Sustainable means that Xhibit considers advertising dynamics to populate the community or promote the brand. It also means that they consider monetization techniques to create long term viability. This ensures that the attractor/community/digital ecosystem is "sustainable."

Xhibit’s services include Digital Business Strategy; Analysis and Consultation; Social Media Strategy and Monetization; Audience Acquisition and Community Design; User Experience and User Interface Design, and Digital Product Brand & Identity. Their services also include Rich Media Design, Video Animation & 3D Modeling; Mobile App/Game Design & Development; Client & Server Platform Design & Development, and Ecommerce, Content Management, Site Security.

In August, Xhibit announced that their co-founder Mr. Chris Richarde resigned his positions as President and Director of the Company, and all positions held with the Company's subsidiaries, effective July 31, 2013. Xhibit is presently undergoing changes to accommodate the Company’s merger earlier this year with SkyMall Ventures and the integration of the two existing operations under a single management group.

Xhibit Corp. (XBTC), closed Monday's trading session at $1.60, up 1.27%, on 79,409 volume with 96 trades. The average volume for the last 60 days is 42,919 and the stock's 52-week low/high is $0.90/$10.01.

AlumiFuel Power Corp. (AFPW)

Purely Penny Stocks and Greenbackers reported earlier on AlumiFuel Power Corp. (AFPW), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

AlumiFuel Power Corp., via their U.S. operating subsidiary, AlumiFuel Power Technologies, Inc., is an early production stage alternative energy company. They generate hydrogen gas and steam for numerous niche applications requiring on-site, on-demand fuel sources. The Company provides “Dry Hydrogen”. The foundation of their novel technology is on the exothermic chemical reaction of aluminum, water, and proprietary additives.

AlumiFuel Power lists on the OTC Markets’ OTCQB. The Company has an operating lab and offices in the Philadelphia, Pennsylvania area. AlumiFuel has a strong Intellectual Property (IP) portfolio: licensed patents as well as proprietary know-how for chemistry, cartridge design, and application.

The Company's hydrogen generation feeds fuel cells for backup and portable power, provides lift gas for weather balloons, and can replace expensive, hard-to-handle, and high pressure K-Cylinders. Its hydrogen/heat output is also undergoing design and development to power fuel cell-based and turbine-based undersea propulsion and auxiliary power systems.

AlumiFuel Power’s technology delivers 5 to 10 times the energy density (runtime) of lithium batteries. It facilitates new power applications with fuel cells and turbines. 

This past July, AlumiFuel Power announced that the earlier announced prospective transaction with Genport, srl of Italy is in the final stages of extensive due diligence. Under the terms of the transaction, AlumiFuel Power's and Genport's assets, Intellectual Property (patents and proprietary expertise), technologies, operations, and products would combine and integrate into a new U.S. alternative energy corporate entity, NovoFuel, Inc.

Upon successful completion of the due diligence, the parties envisage signing a definitive merger agreement through which each would own 50 percent of NovoFuel before any future financings. Genport is an advanced power solutions enterprise.

NovoFuel’s focus would be to pursue and capture backup and portable power applications and business opportunities in the United States and Europe. The new entity would pursue the engineering development of an integrated 5kW backup power system for telecommunications facilities.

AlumiFuel Power Corp. (AFPW), closed Monday's trading session at $0.0009, down 10.00%, on 2,375,190 volume with 16 trades. The average volume for the last 60 days is 4,157,429 and the stock's 52-week low/high is $0.0008/$0.08.

La Jolla Pharmaceutical Co. (LJPC)

Information Solutions Group and PennyTrader Publisher reported previously on La Jolla Pharmaceutical Co. (LJPC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Trading on the OTC Markets’ OTCQB, La Jolla Pharmaceutical Co. develops treatments that significantly improve outcomes in patients with life-threatening diseases. A biopharmaceutical company, La Jolla concentrates on the discovery, development, and commercialization of ground-breaking therapeutics for chronic organ failure and cancer. La Jolla Pharmaceutical has their headquarters in San Diego, California.

The Company’s lead platform technology is targeting the biology of galectin-3.  Galectin-3 is a member of the galectin family of proteins. It has been implicated in chronic organ disease and cancer.  

Currently, La Jolla Pharmaceutical is focusing on the clinical evaluation of GCS-100, a galectin antagonist, as a treatment for chronic organ disease. GCS-100 is presently undergoing evaluation in patients with chronic kidney disease. La Jolla is also focusing on LJPC-501, an antagonist of the renin-angiotensin pathway, as a treatment for hepatorenal syndrome, a life-threatening form of progressive renal failure in patients with liver cirrhosis or fulminant liver failure. 

Moreover, the Company’s team of scientists is expanding their pipeline through developing innovative new therapies to treat diseases of the liver and lung as well as cancer. La Jolla’s scientists are researching the development of a subcutaneous formulation of GCS-100 (LJPC-101), synthetic galectin antagonists (LJPC-201), and biological galectin antagonists (LJPC-301).

In August, La Jolla Pharmaceutical announced that an abstract with data from the Company's Phase 1 clinical trial on galectin-3 and its inverse correlation with kidney function was selected for poster presentation at the annual meeting of the American Society of Nephrology (ASN). Galectin-3 is the target inhibited by GCS-100, La Jolla’s product candidate now in Phase 2 clinical testing.

The ASN meeting will take place November 5-10, 2013 in Atlanta, Georgia. La Jolla's abstract, #4359, entitled "Galectin-3, a Biomarker of Cardiovascular Risk, Inversely Correlates with eGFR," will be presented in a Poster Session titled Pathobiology: Clinical/Diagnostic Renal Pathology and Lab Medicine - 1, on Thursday, November 7, 2013 from 10:00am to 12:00pm.

This week, La Jolla announced that they will present at the Rodman & Renshaw Global Investment Conference. Mr. George F. Tidmarsh, MD, PhD, President and CEO of La Jolla will present at 4:30 pm Eastern Time on Monday, September 9, 2013. The conference will take place in the Millennium Broadway Hotel in New York, New York.

La Jolla Pharmaceutical Co. (LJPC), closed Monday's trading session at $0.077, even for the day, on 238,737 volume with 16 trades. The average volume for the last 60 days is 117,315 and the stock's 52-week low/high is $0.04/$0.135.

American Graphite Technologies, Inc. (AGIN)

PennyStocks24, TooNiceStocks, Wallstreetbuzz, Winston Small Cap, OTCMagic, HEROSTOCKS, VIP STOCK ALERTS, Stockhunter.us, Stock Brain, and Liquid Pennies reported earlier on American Graphite Technologies, Inc. (AGIN), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

American Graphite Technologies, Inc. is a mineral exploration and technology development enterprise. The Company is concentrating on securing graphite mining opportunities and the commercialization of graphene specific proprietary technology methods. The expectation is that graphite demand will increase by more than 50 percent by 2020.

Graphene comes from the carbon atom; accordingly, it is abundant and inexpensive. Graphene is believed to be stronger than steel and more conductive than copper, while being flexible. This makes it practical as a replacement over silicon possibly leading to thinner, faster, cheaper, more flexible devices including power sources. Graphene has been described as the "miracle material" of the 21st Century. Almost all commercial LI-ION batteries use graphite.

Founded in 2012, American Graphite Technologies is based in Las Vegas, Nevada. The Company’s shares trade on the OTC Markets’ OTCQB. The Company previously went by the name Green & Quality Home Life, Inc. They changed their name to American Graphite Technologies, Inc. in July of 2012.

The Company has their Lac Nicolas Graphite Property. They have 100 percent ownership of 100 mineral claims covering approximately 5,400 hectares (13,343 acres) of land in the Province of Quebec. No Royalty or Net Smelter Return (NSR) is attached to this property. The property is in an underexplored relatively new graphite exploration area with major upside potential for new discoveries. It is near a world class high grade graphite deposit, called the Lac Gueret project, belonging to Mason Graphite Corp.

Geologically, the Lac Nicolas Graphite Property is underlain by rocks of Granville Province and Archean basement and is comparable to other graphite deposit/discoveries in the area. The Property is part of the zone designated as "Plan Nord" for major economic, social, as well as environmental development as announced by the Quebec Government.

In July of this year, American Graphite Technologies announced the receipt of the project abstract from Mr. D.V. Vynogradov (SPE RESST KIPT) project manager of the scientific team at the Kharkiv Institute of Physics & Technology (KIPT) in Kharkiv, Ukraine. The project will be a partnership between American Graphite Technologies, Science and Production Establishment "Renewable Energy Sources and Sustainable Technologies" (RESST) National Science Center "KIPT" National Academy of Science of Ukraine and Institute of Solid State Physics and Material Science National Science Center "KIPT" National Academy of Science of Ukraine. The project, named P-600, will research the properties of nanocarbon contained matter (graphene) as working material for 3D printing.

American Graphite Technologies, Inc. (AGIN), closed Monday's trading session at $0.215, down 14.00%, on 268,879 volume with 92 trades. The average volume for the last 60 days is 374,742 and the stock's 52-week low/high is $0.201/$2.00.

Studio One Media, Inc. (SOMD)

SmarTrend Newsletters, SmallCapVoice, Jan Carroll, and FeedBlitz reported earlier on Studio One Media, Inc. (SOMD), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Studio One Media, Inc. is a media and technology company. They engage in the research and development of award winning, proprietary (patents issued and pending), cutting-edge audio and video technologies. These technologies are for professional and consumer use. Studio One subsidiaries and divisions include MyStudio, Inc. and AfterMaster HD Audio Labs, Inc. In 2008, the Company introduced their first product with the installation of their first MyStudio HD Recording Studio.

Studio One Media has their corporate office in Hollywood, California. The Company’s Technical & Operations office is in Scottsdale, Arizona. AfterMaster Studios is based in Hollywood as well. Studio One Media lists on the OTC Markets’ OTCQB.

MyStudio is a self-contained, state-of-the-art, high definition interactive audio/video recording studio. The design of it is for installation in shopping malls and other high traffic areas. MyStudio offers premier quality from a proprietary/patents-pending, stand-alone recording studio. MyStudio and its accompanying website, MyStudio.net, incorporate into a single entertainment venue the video sharing convenience, the social networking appeal, and the talent showcase of other familiar websites and television programs.

MyStudio allows a user, for a fee, to record up to a five-minute personalized video with professional-quality backdrops, lighting, and sound. Users can choose from over 1,000 HD virtual backgrounds (static and dynamic) and thousands of licensed karaoke tracks from EMI Music Publishing and others. The lighting is custom programmed for each virtual background. The sound quality comes from a specially engineered acoustic design and a proprietary audio signal sequencing process.

The Company’s AfterMaster is an innovative audio technology that Studio One Media believes markedly increases the apparent loudness of music while delivering unmatched clarity and depth. The design of the AfterMaster process was to provide consumers with the biggest listening experience possible while reducing the harshness of digital audio and featuring the best qualities of analog recordings. The AfterMaster process achieves its sound without adding compression distortion or exceeding recording industry limits of digital zero. AfterMaster is a proprietary, post-production process. It is applied to the final master of a music mix.

Studio One Media has entered into licensing agreements with Sony/ATV Music Publishing, Universal Music Publishing Group, EMI Music Publishing, and BMG Chrysalis. They have also entered into strategic relationships with industry leaders. These include Mark Burnett Productions, Guitar Center, Back Stage Casting, and others.

Studio One Media, Inc. (SOMD), closed Monday's trading session at $0.26, down 8.77%, on 8,500 volume with 3 trades. The average volume for the last 60 days is 22,496 and the stock's 52-week low/high is $0.125/$0.38.

Titan Energy Worldwide, Inc. (TEWI)

PennyStocks24, The Stock Psycho, Darth Trader, Top Gun, Topgun stockpicks, Real Pennies, and Penny Stock Rumble reported earlier on Titan Energy Worldwide, Inc. (TEWI), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Titan Energy Worldwide, Inc. assists companies in meeting their power generation and energy management needs. To date the Company has concentrated on providing thousands of customers with the most advanced power generation equipment to enable their operations to continue uninterrupted during times of power failures or disasters. Regarding energy management, Titan offers emergency and backup power technologies, demand response programs, and Smart Grid applications, and more.

Titan Energy Worldwide is a leader in distributed power generation products and intelligent energy management services. They serve the disaster recovery; first responder; relief agency; homeland security; Department of Defense, and municipality sectors. Titan serves as a distributor for power generation equipment, a national service provider for onsite power systems, and a manufacturer of advanced monitoring and asset management technologies. 

In 2006, Titan acquired Stellar Energy, a provider of power generation equipment and services. Stellar Energy is now Titan Energy Systems (TES). They've expanded their number of sales and service offices to include Nebraska, Iowa, North and South Dakota, New York, New Jersey, and Connecticut. TES provides Titan Energy Worldwide and their satellite offices with accounting and administrative support. 
Titan, in 2009, acquired the Industrial and Service Division of RB Grove, a power generation provider in Miami, Florida. This company now goes by the name Grove Power, Inc. Grove Power is responsible for Titan's long term goal of expansion throughout the Southeastern United States. Moreover, Titan acquired a power generation business in New Jersey in 2009. They provide the Company with purchase orders, backlog, and broad customer and marketing relationships in New York, Connecticut, and New Jersey. This business merged into TES. 
In 2010, Titan Energy Development, Inc. (TEDI) purchased certain assets and assumed certain liabilities of Stanza Systems, which provides the Company with a software development enterprise experienced in smart grid and utility operations. They operate this business as Stanza Technologies. Stanza has developed network communications software that Titan plans to use in their generator service business.

Last month, Titan Energy Worldwide announced that they released their financial statements for 2Q of 2013. They reported a profit of $281,267 on revenues of $6,434,283. This is in comparison to a loss of $70,137 on revenues of $5,342,261 for the same quarter the year prior. Titan reported that they were profitable for the first six months of 2013, while revenues for the first six months were 31 percent greater than the same period in 2012.  

Titan Energy Worldwide, Inc. (TEWI), closed Monday's trading session at $0.0309, down 0.32%, on 74,000 volume with 5 trades. The average volume for the last 60 days is 433,025 and the stock's 52-week low/high is $0.0048/$0.0684.

El Capitan Precious Metals, Inc. (ECPN)

PennyTrader Publisher and AllPennyStocks reported previously on El Capitan Precious Metals, Inc. (ECPN), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Based in Scottsdale, Arizona, El Capitan Precious Metals, Inc. is an exploration stage company mainly engaging in the exploration of precious metals and other minerals. The Company primarily holds interest in the El Capitan gold-silver property located near Capitan, New Mexico, in Lincoln County. El Capitan Precious Metals' lists on the OTC Bulletin Board.

The Company’s principal asset is their wholly owned subsidiary El Capitan, Ltd., an Arizona corporation. This subsidiary holds the 100 percent equity interest in the El Capitan property. The El Capitan deposit has been known as a potential iron ore resource for several decades. The U.S. Bureau of Mines drilled approximately 140 shallow holes through the outcropping, shallow-dipping magnetite skarn deposit in 1944 and 1948.

The El Capitan property consists of 354 Bureau of Land Management (BLM) lode claims and four patented claims. The claim block occupies approximately 3,000 acres in townships T 7 S, T 8 S, and range R 14 E. A number of recovery methods have been utilized in extracting ore from the El Capitan property. These methods include the alkali fusion method, silver lead collection, as well as carbon pre-roast with silver-lead recovery.

At the end of February 2013, El Capitan Precious Metals announced that they obtained results from a well-respected metallurgical lab that used pre-treatment of the ore and the industry accepted method of cyanide vat leaching. The resulting assays, obtained under "Chain of Custody" procedures, demonstrated significant values of gold along with lesser amounts of other precious metals.

To increase the value of their mining property, El Capitan added this method of precious metal recovery process to the silver-lead recovery process (the Sundancer Method) presently being used. To maximize the recovery of all precious metals, the Company is working with the metallurgical lab to develop further an encompassing recovery process that will include cyanidation recovery and the silver-lead process.

In early June, El Capitan announced that the Company’s ore is undergoing analysis for the recovery values utilizing cyanide leaching. This process is being conducted by the Qualified Person, without any involvement of El Capitan Precious Metals personnel. The work is taking place at five different independent laboratories.

El Capitan Precious Metals, Inc. (ECPN), closed Monday's trading session at $0.095, down 5.00%, on 178,601 volume with 19 trades. The average volume for the last 60 days is 93,167 and the stock's 52-week low/high is $0.0701/$0.1275.

Sauer Energy, Inc. (SENY)

PennyStockLocks.com, OTCPicks, Penny Stock Rumble, and PennyTrader Publisher reported previously on Sauer Energy, Inc. (SENY), and we report today on the Company, here at the QualityStocks Daily Newsletter.

Sauer Energy, Inc. is a technology developer and manufacturer focusing on the emerging renewable energy market. The Company is the developer of the patented WindCharger™ brand vertical axis wind turbine (VAWT) and also the manufacturer of the patented HelixWind® vertical axis wind turbine. Sauer Energy is based in Camarillo, California. The Company’s shares trade on the OTC Markets’ OTCQB.

The Company’s technology, because it requires few parts, provides a new direction for wind capture, scales easily from residential to small community and up to large industrial scale. The Company has created the WindCharger™ model to provide a better solution for the use of wind capture for residential or small building use. 

The WindCharger™ is one of Sauer Energy's key innovation priorities. The Company has several patents in place and more pending. The focus of the WindCharger™ and Helix turbines has centered on patented disruptive technology, minimum impact on the environment, mounting flexibility, and versatility with highly efficient output. Sauer and Helix turbines underwent development to produce a quiet and low-impact technology with a high output of sustainable renewable energy.

With the acquisition of the assets of Helix Wind, Sauer Energy plans to be able to offer the Helix vertical axis wind turbine systems in the near future. The design of them is specifically to be pole mounted and can respond to the demand for applications that do not necessitate roof mounting.

This past June, Sauer Energy announced that they applied for key new patents in late May and early June 2013. This is to further consolidate and protect the Company’s position as a foremost developer of vertical axis wind technology. The filings cover both of their core proprietary products, the WindCharger™ and HelixWind® turbines. The most important filing pertained to a synergistically designed system to give their wind-powered turbines full portability. 

Sauer Energy, Inc. (SENY), closed Monday's trading session at $0.181, down 9.50%, on 219,729 volume with 50 trades. The average volume for the last 60 days is 71,323 and the stock's 52-week low/high is $0.0785/$0.40.


The QualityStocks
Company Corner


Calpian, Inc. (CLPI)

The QualityStocks Daily Newsletter would like to spotlight Calpian, Inc. (CLPI). Today, Calpian, Inc. closed trading at $1.35, up 3.85%, on 400 volume with 1 trade. The stock’s average daily volume over the past 60 days is 3,016, and its 52-week low/high is $0.88/$2.75.

Calpian, Inc. announced today that, as of August 31, 2013, the Money-on-Mobile service offered by its Indian subsidiary is now being supported by 157,860 retail locations, an increase of 6,330 stores from 151,530 stores on July 31, 2013. Additionally, Money-on-Mobile was accessed by approximately 67.5 million unique phone number customers from inception through August 31, 2013, up from the 62.6 million reported from the previous month.

Calpian, Inc. (CLPI) has forged a powerful combination of steady cash flow here in the U.S. on the one hand, and explosive growth potential abroad in India on the other. Both business units are growing fast and creating huge value that has so far gone largely overlooked due to the company’s rapid rise.

Calpian is a leader in the U.S. business for providing access to credit and debit card payment processors for merchants and also for making investments in the resulting cash flow streams. Calpian's management team, with over 60 years of combined experience in payments, has also tapped into a super-hot growth opportunity in India where it is the leader in consumer payments using the cell phone - the most powerful financial trend in the developing world today. The company's revenues in India grew 300% year to year and are headed for triple digit growth again in 2013. Examples of this service in other countries like Kenya show that consumers need this simple payment tool and adopt it quickly. In Kenya, over 90% of the adult population has adopted a mobile phone money transfer system known as M-PESA, which produces over $100 million pretax profit after only 7 years in business. Calpian is providing this same service in India via Money on Mobile (MoM). India is a market at least 30 times larger than Kenya with vast potential. Calpian is the undisputed market leader in the space and looks poised to dominate the largest market for this service in the world with almost 1 billion cell phones.

In the U.S., the company has carved out a solid niche in the growing $1B plus annual residuals space for credit card usage by providing a silver bullet solution including their own gateway that merchants use to connect with large payment processors. Calpian is providing its merchant services through its wholly owned subsidiary, Calpian Commerce continues to sign merchants to card processing contracts, while Calpian itself continues acquiring additional recurring monthly cash flows from the over 10,000 smaller Independent Sales Organizations (dealers) throughout the U.S. The management team has been together for decades refining this business model through over 200 acquisitions in their careers before making it public in 2010. The team is experienced and well known throughout the industry as the go-to guys for making a deal.

In India, with Calpian acquiring an interest in March 2012 in Digital Payments Processing Limited (DPPL), which delivers the payment processing service for the Money on Mobile solution, it has taken off with incredible force, signing an incredible 53 million consumers though its vast network of 143,000 retailers (and growing at least 3,000 per month) so far. This astonishing growth is thanks in large part to how elegantly the company's mobile payment application, which is already seen as the “PayPal” of India, satisfies all the needs of the average Indian consumer, distributor, and retailer alike. The vast swathes of under-banked and unbanked consumers in India represent the tip of a much larger global iceberg for this solution as well, a solution whose backbone is simple SMS text protocol, and which bundles all the right incentives together for emerging markets. MoM is the runaway leader at this time in India pacing at 20 times larger than its nearest competitor. Disclaimer

Calpian, Inc. Company Blog

Calpian, Inc. News:

Calpian’s Money on Mobile Service Serves over 67 Million Users

Calpian to Present at the 15th Annual Rodman and Renshaw Conference

Calpian’s Money-on-Mobile Grows to Serve over 57 Million Unique Users

Epazz Inc. (EPAZ)

The QualityStocks Daily Newsletter would like to spotlight Epazz Inc. (EPAZ). Today, Epazz Inc. closed trading at $0.0011, even with yesterday's close, on 6,560,355 volume with 68 trades. The stock’s average daily volume over the past 60 days is 16,074,471 and its 52-week low/high is $0.0006/$0.0125.

Epazz, Inc. announced today that the Company is effectively transitioning to a holding company with the filing of articles of amendments on its Subsidiaries. According to Shaun Passley, CEO of EPAZ, they will be will be incorporating new companies in the coming weeks and shareholders were reminded that the record date for Project Flex Spin-off is September 15, 2013, and in order to receive the stock dividend they need to have the share settle three days prior to the record date.

Epazz Inc. (EPAZ) is a leading cloud-based software company focused on providing customized cloud applications to Fortune 500 enterprises, government agencies, and higher education institutions. Targeting a strong growth industry, the company is rapidly expanding via strategic acquisitions, a full suite of in-house products and services, and diversified streams of income.

The fully reporting company is demonstrating substantial performance in a competitive industry, completing six acquisitions while maintaining organic subsidiary growth. In the last three years, Epazz revenues have increased by more than 300%. The company will produce its first spinoff with “Project Flex” and issue a stock dividend to shareholders of record on the record date.

As an enterprise-wide software company, Epazz is adeptly serving the increasing information technology demand of the 21st century. According to IDC, the premiere global market intelligence firm, the IT cloud services industry is expected to grow from $40 billion to $100 billion in just four years. Management anticipates the company’s growth to accelerate as the market for its technology solutions continues to expand.

Epazz BoxesOS™ v3.0 is the complete business web-based software package for small to mid-size businesses, Fortune 500 enterprises, government agencies, and higher education institutions. The turnkey enterprise system, which includes content, integration, customization, and marketing services, provides many of the web-based applications organizations would have to otherwise buy separately. Disclaimer

Epazz Inc. Blog

Epazz Inc. News:

Epazz Files Articles of Amendments on Its Subsidiaries as Part of Its Transition Plan to Become a Holding Company

Epazz Reaches Over 60 Million Shares on Short Sales Report for August 2013

Epazz Stock Dividend Reminder: Project Flex Spin-Off Record Date Set for September 15, 2013

NanoTech Entertainment, Inc. (NTEK)

The QualityStocks Daily Newsletter would like to spotlight NanoTech Entertainment, Inc. (NTEK). Today, NanoTech Entertainment, Inc. closed trading at $0.0735, off by 6.37%, on 2,063,933 volume with 147 trades. The stock’s average daily volume over the past 60 days is 8,212,771, and its 52-week low/high is $0.0005/$0.1395.

NanoTech Entertainment, Inc. announced today the addition of Jim Rossi to the NanoTech Executive Team. Rossi’s dedication and over fifteen years of experience in service & support enables him to be a great fit for NanoTech as the company experiences unprecedented growth with the release of several consumer products this quarter and Rossi brings his experience at other notable companies to the table with him, major industry players like Hewlett-Packard, Quantum3D and most recently YoYo Text, where he served in similar positions.

NanoTech Entertainment, Inc. (NTEK) is a conglomerate of entertainment companies focused on leveraging technology to deliver state-of-the-art entertainment and communications products. The company’s team is comprised of senior individuals who have been in the entertainment industry for more than 20 years and have a long track record of creating successful products.

Leveraging a diverse portfolio of products and technology, NanoTech is redefining the role of developers and manufacturers in the global market. The company has a unique business model with four technology business units focusing on gaming, media & IPTV, mobile apps, and manufacturing.

NanoTech’s Gaming Labs division operates as a virtual manufacturer, developing its technology and games, and licensing them to third parties for manufacturing and distribution in order to keep its overhead extremely low and operations efficient in the new global manufacturing economy. NanoTech Media develops proprietary technology which it licenses to publishers for use in their products as well as creating and publishing unique content. NanoTech Communications develops and sells proprietary apps and technology in the mobile and consumer space. Clear Memories is the global leader in 3D ice carving and manufacturing technology.

In a recent move to advance into the commercial media space, NanoTech signed a definitive agreement to acquire MagicScreen3D, a leader in the commercial implementation of glassless 3D screen technology. The company is focused on accelerating its corporate growth through additional acquisitions, licensing agreements, partnerships, and executing current business strategies. Leveraging its team’s expertise, NanoTech is well positioned to achieve greater success. Disclaimer

NanoTech Entertainment, Inc. Company Blog

NanoTech Entertainment, Inc. News:

NanoTech Entertainment Appoints Jim Rossi VP of Business Services

NanoTech Entertainment to Stream the International Wine Channel TV Awards Live

NanoTech Entertainment Reports Record Quarterly and Annual Revenue

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.15, on 2,528,721 volume with 174 trades. The stock’s average daily volume over the past 60 days is 388,391, and its 52-week low/high is $0.13/$0.41.

International Stem Cell Corp. announced further progress today in its Parkinson's disease program with a recently held key opinion leader meeting facilitated by the study's principal investigator, Dr. Mark Stacy of Duke Medicine. The meeting was a significant step towards clinical studies to evaluate the use of stem cell-derived neuronal cells to treat Parkinson's disease and it increases the chances of a successful clinical outcome by ISCO to not only build on previous studies, but also gain in-depth insight from some of the principal clinicians and neurosurgeons working in this field.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.

A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.

In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Advances Parkinson's Disease Program Towards IND Stage

International Stem Cell Corp. to Present at Rodman & Renshaw 15th Annual Global Investment Conference September 8th to 10th

International Stem Cell Corporation Enters Into Clinical Research Agreement for Parkinson's Disease Program

Calpian, Inc. (CLPI) Says Money-on-Mobile Achieves Sequential Growth, Reaches Nearly 68 Million Users

Calpian, a U.S.-based company focused on mobile payments emerging-market operations through its subsidiary in India, today reports that as of August 31, 2013, the Money-on-Mobile (MOM) service offered by its Indian subsidiary is available now at 157,860 retail locations, an increase of 6,330 stores from 151,530 stores at the end of July 2013. Furthermore, MOM was accessed by nearly 68 million unique phone number customers from inception through August 31, 2013, up from nearly 63 million reported from the previous month.

“Money-on-Mobile continues to show an increased growth rate in stores participating in the system,” Calpian CEO Harold Montgomery stated in the press release. “Whereas we had added 3,000 to 4,000 stores per month, in the last two months we have added over 8,000 and over 6,000 respectively. Month after month we are seeing further evidence of the increase in popularity of our Money-on-Mobile service.”

MOM is a stored-value mobile payments service that gives consumers in India the ability to use their mobile phones to pay for goods and services or transfer funds from one cell phone to another using SMS text functionality.

CLPI says that processed transaction volume for August 2013, measured in Indian rupees, topped 933 million INR, a gain of about 2 percent from the previous month.

“We are very pleased to see a volume increase in August relative to July,” MOM Managing Director Shashank Joshi said. “There are three big holidays in India in August including our National Independence Day on August 15th. Despite this, we showed solid volume growth from July to August.”

At current exchange rates, August processed transaction volume was approximately $14.2 million, down from $15.0 million in July as the value Indian rupee sagged 10 percent during August.

For more information, visit www.calpian.com

Epazz, Inc. (EPAZ) Files Articles of Amendments, Advances Transition Toward Becoming a Holding Company

Epazz, a provider of cloud-based business software solutions for government, higher education, and the private sector, today said it has filed articles of amendments on its subsidiaries in order to effectively transition into a holding company via acquisitions and spin-offs.

“We are making the necessary changes to become a holding company. We will be incorporating new companies in the coming weeks,” EPAZ CEO Shaun Passley stated in the press release.

EPAZ intends on acquiring additional software companies to grow its revenues and assets for a possible listing on a stock exchange.

The record date for the company’s previously announced Project Flex spin-off is September 15, 2013, with a $0.01 dividend payable only to shareholders that have the share settle three days prior to the record date.

EPAZ approved a 1-10 stock dividend for its shareholders. For each 10 shares of EPAZ common stock that a shareholder owns, the shareholder will receive one share of stock in the new Project Flex spinoff.

For more information, visit www.epazz.com

International Stem Cell Corp. (ISCO) Advances Progress of Parkinson’s Disease Treatment Program

California-based biotechnology company, International Stem Cell Corp. announced updates on the progress of its Parkinson’s disease (PD) program this morning. The updates followed a recent meeting of key opinion leaders, which was facilitated by the study’s principal investigator, Dr. Mark Stacy of Duke Medicine. The meeting was a significant step toward launching clinical studies to evaluate the use of stem cell-derived neuronal cells in treating Parkinson’s disease.

“This is an interesting new approach for the treatment of PD,” remarked Dr. Stacy. “This meeting increases the chances of a successful clinical outcome by allowing us to not only build on previous studies, but also gain in-depth insight from some of the principal clinicians and neurosurgeons working in this field.”

By bringing together leading experts in the field of cell therapy and movement disorders, ISCO gained critical feedback and guidance that can be included in the final pre-clinical primate studies and the design of the first–in-man study, which is expected to begin in 2014.

The participants (including a number of pre-eminent clinicians who have conducted cell therapy trials using fetal-derived tissue) discussed the trial’s study design, including where in the brain the cells will be implanted, the necessity for placebo controls, and the duration that may be required to see clinically meaningful changes.

“There is still much debate in the literature concerning the most effective ways to treat Parkinson’s patients with human cells. Gathering such a distinguished clinical group together helped answer a number of open questions regarding the phase I clinical study,” commented ISCC’s Chief Scientific Officer, Dr. Ruslan Semechkin. “It’s a testament to Dr. Stacy and Duke’s reputation in this area to be able to draw together such experience; we feel very confident that we have the right approach and every chance for a successful IND and subsequent phase I study.”

For additional information, visit www.InternationalStemCell.com

Advaxis, Inc. (ADXS) is Sending the Right Signals

Without question, Biotech companies can generate some of the most explosive returns on Wall Street. It’s not unusual to see 10 to 20 times return when a Biotech company gets approval for a new blockbuster drug or treatment. Conversely, these same high flyers can go bust almost overnight so it’s important to know the signals to look for when searching for the next big winner. When picking Biotech stocks, it’s about the risk-reward ratio.

One biotech company could be sending out just the right signals and may be poised for explosive performance. With the development and clinical trials of its innovative immunotherapy technology for treating multiple cancers, Advaxis is sending signals that investors should take into serious consideration.

Even though Advaxis is a development stage Biotech Company, the promise this immunotherapy technology holds for treatment of cervical cancer alone make it worth serious consideration. The company has targeted cancers related to HPV (human papillomavirus). HPV is a common sexually transmitted virus that typically has few side effects. However, in some cases repeated or untreated infections can lead to cervical and other types of cancer. Cervical cancer is the second most common cancer in women, and the fifth deadliest around the world. In clinical trials Advaxis already has shown remarkable efficacy in treating late stage cervical cancer.

Advaxis utilizes a bioengineered strain of bacterium (Listeria Monocytogenes) to trigger the body’s own immune response system. This novel patent-protected approach redirects the body’s natural and powerful immune responses to the engineered bacterium to the cancers themselves. This process also holds early promise for the treatment of anal cancers and head and neck cancer.

Besides the science, there are other factors to consider in Risk vs. Reward with Biotech. Experienced management is imperative to success and Advaxis has a strong, experienced team. Their key personnel have shepherded other Biotech companies to huge successes. Product pipeline and FDA approval are always concerns. Advaxis currently has multiple clinical trials and strategic collaborations underway in addition to filing multiple orphan drug designations with the FDA. Orphan drug designation often leads to FDA flexibility and the early approval of novel therapeutics. Cash burn is the Achilles heel of most development stage Biotech companies, but the cash burn of Advaxis is offset by a private equity commitment that easily should fund them through Phase III trials.

Taken together as whole: the science, the management, the financing, and the market commercialization risk; it would appear that the risk reward ratio for Advaxis is skewed heavily in favor of the investor. In fact, a recent Seeking Alpha article suggests that Advaxis may very well be currently undervalued by more than eight fold (http://seekingalpha.com/article/1678582-6-reasons-advaxis-may-be-the-best-reward-vs-risk-in-healthcare). An eight fold return at current valuations makes the risk-reward ratio of Advaxis more than just interesting.

For more information, visit www.advaxis.com


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Penny Stock Gains


FOX Penny Stocks


Real Pennies

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251